Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis

Locally manufactured chimeric antigen receptor T-cell (CAR T) therapy enables rapid manufacturing and a substantially shorter vein-to-vein time. However, its clinical efficacy compared to commercial CAR T products remains unclear. This retrospective study compared outcomes in patients with Large B-...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ronit Marcus, Abraham Avigdor, Uri Greenbaum, Samantha Brown, Shalev Fried, Noa Golan-Accav, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Elad Jacoby, Arnon Nagler, Avichai Shimoni, Orit Itzhaki, Jonathan Esensten, Ori Ben Valid, Annamaria Ballweg, Xavier Deschênes-Simard, Efrat Luttwak, Gunjan Shah, Michael Scordo, Parastoo Dahi, Miguel-Angel Perales, Tsila Zuckerman, Sean M. Devlin, Dana Yehudai-Ofir, Hazim Khatib, Nivin Shibly, Roni Shouval, Ofrat Beyar-Katz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Ferrata Storti Foundation 2025-12-01
Цуврал:	Haematologica
Онлайн хандалт:	https://haematologica.org/article/view/13066
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!